Shanghai Xiao Fang Pharmaceutical Co.,Ltd.

¥22.66As of Sun 8 Nov 2026, 12:00 UTC
SSE:603207Healthcare
Country China
PE (Fwd) •••
TSR 2Y CAGR (5.18%)
Div yield 4.72%
ROE 17.66%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.11
PE TTM 19.02
TSR TTM (27.59%)
Mkt cap ¥3.666B
ROIC 42.30%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥23
1.68%
(74.00%)
Hold 0|8|1|9|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.30
0.31
0.31
0.31
0.89%
5.76%
9.74%
13.62%
Revenue¥M
322.5
324.3
320.9
312.8
12.50%
7.82%
1.69%
(1.07%)
Peers (US$548.8M)
Cap (US$)
PE
552.2M
149.0x
Capital
TTM
5Y
10Y
Leveragex
0.294
2.937
2.326
EBIT/Intx
0.415
0.283
0.330
Own earn%
(14.36)
(13.85)
(19.45)
Sh yield%
17.24
22.61
21.47
Owners
Insiders/Inst%
8.59
65.53
Short interest%
3.37
SBC / revenue%
1.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
0–6
$1 testx
—
Incr. ROIC%
3